Selvita Reports Rebound in H2 2024 and 11% Increase in Backlog for 2025 ...Middle East

PR Newswire - News

KRAKOW, Poland, March 27, 2025 /PRNewswire/ -- Selvita S.A. (WSE: SLV), one of Europe's leading preclinical CROs, has announced its financial results for 2024 and provided an update on its backlog for 2025. Key Highlights: In Q4 2024, Selvita generated EUR 22.5 million in commercial...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Selvita Reports Rebound in H2 2024 and 11% Increase in Backlog for 2025 )

    Apple Storegoogle play

    Also on site :